Monday, June 9, 2014

55-year-old man undergoing cystography after motor vehicle collision

Cystogram image is shown below
There is contrast in the bladder.
 True
 False

There is contrast in the perivesical space.
 True
 False

There is contrast in the peritoneal cavity.
 True
 False


CT images of the abdomen and pelvis
Images from unenhanced CT the abdomen and pelvis performed immediately after cystogram are shown below







What is the final diagnosis?
 Ureteral injury
 Extraperitoneal bladder rupture
 Collecting system injury
 Intraperitoneal bladder rupture

What is the next step in management? 
 Additional imaging to evaluate the bladder.
 Transurethral Foley catheter drainage
 Suprapubic catheter drainage
 Operative management









Findings and diagnosis

Findings
  • Cystogram
    • Extravasation from the urinary bladder into the peritoneal cavity, with contrast extending into the paracolic gutters
    • Metallic density in the left pelvis, consistent with shrapnel
  • Unenhanced CT of the abdomen and pelvis, performed immediately after cystogram
    • Large amount of intraperitoneal high-density fluid in the subhepatic space, paracolic gutters and within the peritoneal cavity, representing contrast from cystogram performed prior to the CT scan
Differential diagnosis
  • Intraperitoneal bladder rupture
  • Extraperitoneal bladder rupture
  • Ureteral injury
  • Collecting system injury
Diagnosis: Intraperitoneal bladder rupture






http://www.auntminnie.com/images/onlinece/00-bit.gifDiscussion
  • Etiology
    • Bladder injury is most commonly seen in the setting of motor vehicle collisions.
    • Bladder trauma occurs from blunt injury and penetrating or iatrogenic trauma.
    • Often associated with pelvic fractures.
       
  • Classification of bladder injury
     
    • Type 1: Simple bladder contusion is a mucosal injury and does not have detectable abnormalities on imaging studies.
       
    • Type 2: Intraperitoneal rupture is the result of a direct blow to an already distended bladder, which increases intraluminal pressure and causes rupture of the dome of the bladder. Intraperitoneal bladder injury accounts for about one-third of all major bladder injuries.
       
    • Type 3: Interstitial injury is an intramural or partial thickness laceration with an intact serosa. This type of injury is rare and would be difficult to recognize on imaging studies.
       
    • Type 4: Extraperitoneal rupture is the most common type of bladder injury, and accounts for approximately 60% of major bladder injuries.
       
      • Type 4A: Simple extraperitoneal rupture has extravasation limited to the perivesical space.
      • Type 4B: Complicated extraperitoneal rupture has extravasation beyond the perivesical space.
         
    • Type 5: Combined injury is a combination of intraperitoneal and extraperitoneal injury, and accounts for 5% of all bladder injuries.
       
  • Clinical presentation
    • Gross hematuria
    • Suprapubic pain
    • Anuria
    • Decreased bowel sounds (with intraperitoneal injury)
    • Acute abdomen (with intraperitoneal injury)
       
  • Laboratory findings
    • Urinanalysis will demonstrate hematuria.
    • Peritoneal lavage fluid will be consistent with urine.
       
  • Imaging recommendations
    • Cystography -- CT or conventional (equal sensitivity).
    • Exclude urethral injury in males before performing cystography.
    • Check postdrainage films to identify extravasation that was hidden by contrast.
       
  • Radiographic findings
    • Cystography
      • Bladder contusion: Usually not recognized by imaging, but may have teardrop appearance of bladder due to extrinsic compression of bladder by bladder hematoma.
      • Intraperitoneal: Extravasation of contrast around bowel loops, paracolic gutters, pouch of Douglas, and intraperitoneal viscera.
      • Interstitial injury: Focal defect along the wall of the bladder may be seen, but is difficult to recognize on imaging.
      • Extraperitoneal:
        • Simple: Extravasation around the bladder.
        • Complex: Extravasation extends beyond the pelvis.
      • Combined: Findings of both intraperitoneal and extraperitoneal rupture.
    • CT cystography
      • Contusion: Normal appearance.
      • Intraperitoneal: Same findings as conventional cystogram.
      • Interstitial: Extravasation of contrast intramurally and submucosally without transmural extension, but difficult to recognize on imaging.
      • Extraperitoneal rupture:
        • Simple: Contrast is confined to perivesical space.
        • Complex: Contrast extends beyond the perivesical space.
        • "Molar tooth" sign -- rounded superiorly with pointed inferior contours.
    • Ultrasound
      • Fluid around the bladder
      • Hematoma within bladder wall
         
  • Complications include fistulas, abscess, sepsis, hematoma, and hemorrhage.
     
  • Management is determined by classification of injury.
    • Contusions and interstitial injuries are managed conservatively with Foley catheterization.
    • Intraperitoneal injury requires laparotomy and surgical repair of bladder injury.
    • Extraperitoneal injury is usually treated with catheter drainage. If there is complicated extraperitoneal rupture, then surgical repair may be necessary.
       
  • Follow-up: Perform cystography 10 days after initiation of treatment.
References
1.     Chan DP, Abujudeh HH, Cushing GL Jr, Novelline RA. CT cystography with multiplanar reformation for suspected bladder rupture: Experience in 234 cases. AJR Am J Roentgenol. 2006:187(5);1296-1302.
2.     Ramchandani P, Buckler PM. Imaging of genitourinary trauma. AJR Am J Roentgenol. 2009;192(6):1514-23..
Vaccaro JP, Brody JM. CT cystography in the evaluation of major bladder trauma. Radiographics.2000;20(5):1373-1381.

Welcome to the Urology Congress 2014. The Bay Hotel, Camps Bay, Cape Town, South Africa

http://urology2014.co.za/general-info/registrations/

Saturday, June 7, 2014

Practice Update register

http://www.practiceupdate.com/urology?elsca1=emc_acq_splty-uro_elspu_20140602&elsca2=email&elsca3=capri&elsca4=20140602_picture&elsca5=acquisition

'Quadrapeutics' makes cancer cells explode

Colloidal gold is the explosive, a near infrared laser pulse the detonator in a new anti-cancer technology developed by researchers from Rice University, the University of Texas MD Anderson Cancer Center and Northeastern University. They coined their method quadrapeutics. It consists of a novel combination of existing clinical treatments that instantaneously detects and kills cancer cells without harming healthy tissue. InNature Medicine they report that it was 17 times more efficient than conventional chemoradiation therapy against aggressive, drug-resistant head and neck tumours.

Quadrapeutics was designed to address aggressive cancers that cannot be efficiently and safely treated, like tumours that are intertwined with important organs or have become resistant to chemoradiation. Quadrapeutics differs from other cancer treatments in that it radically amplifies the intracellular effect of drugs and radiation only in cancer cells. The quadrapeutic effects are achieved by mechanical events - tiny, remotely triggered nano-explosions called ‘plasmonic nanobubbles’. Plasmonic nanobubbles are non-stationary vapors that expand and burst inside cancer cells in response to a short, low-energy laser pulse.

"Quadrapeutics shifts the therapeutic paradigm for cancer from materials - drugs or nanoparticles - to mechanical events that are triggered on demand only inside cancer cells," Dmitri Lapotko, the study’s lead investigator said. "Another strategic innovation is in complementing current macrotherapies with microtreatment. We literally bring surgery, chemotherapies and radiation therapies inside cancer cells."

The first component of quadrapeutics is a low dose of a clinically validated chemotherapy drug. The team tested encapsulated versions of doxorubicin and paclitaxel that were tagged with antibodies to target cancer cells. Thanks to the magnifying effect of the plasmonic nanobubbles, the intracellular dose is very high even when the patient receives only a few percent of the typical clinical dose.
The second component is an injectable solution of nontoxic gold colloids, also tagged with cancer-specific and clinically approved antibodies that cause them to accumulate and cluster together inside cancer cells. These gold ‘nanoclusters’ do nothing until activated by a laser pulse, which is the third quadrapeutic component. The investigators used short near-infrared laser pulses. A standard endoscope delivers the laser pulse to the tumour, where the gold nanoclusters convert the laser energy into plasmonic nanobubbles.

The fourth component is a single, low dose of radiation. The gold nanoclusters also amplify the deadly effects of radiation only inside cancer cells, even when the overall dose to the patient is just a few percent of the typical clinical dose.

Head and neck
In the Nature Medicine study, the team tested quadrapeutics against head and neck squamous cell carcinoma (HNSCC) that had grown resistant to both chemotherapy drugs and radiation.1 Quadrapeutics proved so deadly against HNSCC that a single treatment using just 3 percent of the typical drug dose and 6 percent of the typical radiation dose effectively eliminated tumours in mice within one week of the administration of quadrapeutics.

Lapotko is now working with colleagues at MD Anderson and Northeastern to move as rapidly as possible toward prototyping and a human clinical trial. In clinical applications, quadrapeutics will be applied as either a stand-alone or intra-operative procedure using standard endoscopes and other clinical equipment and encapsulated drugs such as Doxil or Lipoplatin. Lapotko believes that quadrapeutics is a universal technology that can be applied for local treatment of various solid tumours, including other hard-to-treat types of brain, lung and prostate cancer. He said it might also prove especially useful for treating children due to its safety.


Friday, June 6, 2014

American Urological Association (AUA) 2014 Annual Scientific Meeting May 16 - 21, 2014; Orlando, Florida This coverage is not sanctioned by, nor a part of, the American Urological Association

CONFERENCE NEWS

Medscape Medical News, May 29, 2014
Medscape Medical News, May 28, 2014
15 comments
Medscape Medical News, May 27, 2014
Medscape Medical News, May 27, 2014
1 comment
Medscape Medical News, May 23, 2014
3 comments
Medscape Medical News, May 22, 2014
1 comment
Medscape Medical News, May 22, 2014
5 comments
Medscape Medical News, May 21, 2014
Medscape Medical News, May 20, 2014
1 comment
Medscape Medical News, May 19, 2014
16 comments
Medscape Medical News, May 18, 2014
1 comment
Medscape Medical News, May 18, 2014
7 comments
Medscape Medical News, May 17, 2014
Medscape Medical News, May 17, 2014
8 comments
Medscape Medical News, May 17, 2014
23 comments
·         What's Hot at AUA 2014

Medscape Medical News, May 13, 2014

Twitter Delicious Facebook Digg Stumbleupon Favorites More

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Bluehost Review